Resources & Guides
Educational content about GLP-1 medications, pharmacokinetics, and optimizing your treatment journey.
GLP-1 Medication Hubs
Comprehensive guides for each GLP-1 medication—dosing protocols, clinical trial data, microdosing strategies, and our free calculators.
Semaglutide Guide
Ozempic & Wegovy: GLP-1 receptor agonist. ~15% weight loss, 7-day half-life. FDA-approved for diabetes and weight management.
Tirzepatide Guide
Mounjaro & Zepbound: Dual GLP-1/GIP agonist. ~21% weight loss, 5-day half-life. The first dual-agonist approved by FDA.
Retatrutide Guide
Triple GLP-1/GIP/Glucagon agonist. ~24% weight loss in trials, 6-day half-life. Expected FDA approval 2027.
Educational Content
LillyDirect Mounjaro: Flat $499 Self-Pay Price, Pen Only (2026)
articleWhat Mounjaro actually costs through LillyDirect, why the price does not step up by dose, and how the $25 savings card compares for insured patients.
Compounded Tirzepatide: What You Need to Know (2026 Guide)
articleCompounded tirzepatide costs a fraction of Mounjaro or Zepbound — see our full <a href="/resources/tirzepatide-cost" style="color: #2563eb;">tirzepatide cost guide</a> but sits at the center of an ongoing legal battle between Eli Lilly, compounding pharmacies, and the FDA. This guide covers the regulatory landscape after the October 2024 shortage removal, how to source safely, dosing considerations, reconstitution, storage, and what the court rulings mean for availability.
Compounded Semaglutide: Cost, Safety & How to Source (2026)
articleCompounded semaglutide costs a fraction of Ozempic or Wegovy but carries distinct risks. This guide covers the FDA regulatory landscape after the 2025 shortage resolution, how to source safely from legitimate pharmacies, dosing considerations, reconstitution, storage, and red flags to watch for.